We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that...
Crown Bioscience, a global drug discovery and development services company, opened a new facility in San Diego, CA. The new site will become CrownBio’s International Center of Excellence for oncology biomarker and inflammation services.